
Sign up to save your podcasts
Or


In July 2019 the FDA asked Allergan to voluntarily recall BIOCELL textured breast implants and tissue expanders due to uncommon incidence of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Dr. Martin and Amy dive into what we know about the recall, what the risks are, and what the future holds for textured implants.
By Jason Martin MD4.8
6666 ratings
In July 2019 the FDA asked Allergan to voluntarily recall BIOCELL textured breast implants and tissue expanders due to uncommon incidence of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Dr. Martin and Amy dive into what we know about the recall, what the risks are, and what the future holds for textured implants.

1,112 Listeners

12,035 Listeners

14,972 Listeners

7,272 Listeners

1,142 Listeners

915 Listeners

638 Listeners

4,078 Listeners

616 Listeners

90 Listeners

1,236 Listeners

140 Listeners

1,046 Listeners

1,183 Listeners

166 Listeners